Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study Evaluating DUOBRII in Psoriasis Patients Being Treated With Biologic Agents.

NCT04119102 is registered in ClinicalTrials.gov with Psoriasis Treatment Center of Central New Jersey as lead sponsor.

NCT NCT04119102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04119102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study Evaluating DUOBRII in Psoriasis Patients Being Treated With Biologic Agents.
Lead sponsor
Psoriasis Treatment Center of Central New Jersey
Phase
Phase 4
Overall status
Recruiting
Start date
October 14, 2019
Completion date
September 1, 2020
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis